Company Details
Geneplus-Beijing Co. Ltd.
Beijing, China
Overview
Geneplus Technology, also known as Gene+, is a China-based company. The company announced it secured 750 million yuan (about $116 million) in a Series C financing. The round was reported as being led by CCB International, the venture unit of China Construction Bank. The financing was disclosed in a company statement on Thursday. The article does not provide details on the company’s products, operating metrics, use of proceeds, or prior rounds.
- Total raised
- $116M
- Funding rounds
- 1
- Latest round
- Series C
- Latest activity
- Jul 2021
Industries
- Biotechnology
- Health Diagnostics
- Oncology
Recent funding
Series C
Jul 2021
$116M
Team
Xin Yi
Co-Founder, Chairman, Chief Executive Officer
Ling Yang
President & Co-Founder